Xellar Biosystems

Xellar Biosystems

Biotechnology Research

Boston, Massachusetts 2,550 followers

Providing a unique and comprehensive three-pronged approach to drug discovery using Organ-on-a-Chip technology.

About us

The human body is a holistic system, its biology is multi-faceted and intricately interconnected. Traditional drug discovery and development efforts have relied on simplified models and reductionistic tools to discover and test new drugs. Now it's time to make a change. Xellar is a Wet-AI, Artificial Intelligence and machine learning combined with large-scale wet-lab experiments, biotech company tackling the most challenging problem in modern drug discovery – harnessing the complexity of human biology to accelerate drug discovery and development.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Partnership
Founded
2022
Specialties
Artificial Intelligence, High Throughput Screening, Organ-on-chip, Morphological Profiling, Image-based Drug Discovery, Lab Automation, microfluidics, 3D cell culture, Micro-physiological Systems , Disease Modeling, and Machine Learning

Locations

Employees at Xellar Biosystems

Updates

Similar pages

Browse jobs

Funding

Xellar Biosystems 1 total round

Last Round

Seed

US$ 13.8M

See more info on crunchbase